<DOC>
	<DOC>NCT02010918</DOC>
	<brief_summary>The purpose of this study is to determine whether 500 mg Glucosamine Sulfate / 400 mg Chondroitin Sulfate Capsules and 1500 mg Glucosamine Sulfate / 1200 mg Chondroitin Sulfate Sachet is effective and safe compared Cosamin DS ® Capsule in Treatment of Knee Osteoarthritis.</brief_summary>
	<brief_title>Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis</brief_title>
	<detailed_description>The Groups receive treatment for 16 weeks. The study is realized in 16 sites in Brazil.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Male or female patient, older than 40 years of age, with knee osteoarthritis, based on clinical and radiological criteria (KellgrenLawrence grade 2 3), as specified: 1. Pain on movement of the affected knee for more than 15 days in the previous month with at least partial relief at rest; 2. Presence of osteophytes at least 1 mm in radiological imaging; Knee osteoarthritis symptoms for at least six months prior to randomization. Concomitant arthropathy that may confuse or interfere with assessing the efficacy or pain; Patellar disease isolated, with primary symptoms of pain in the anterior knee, in the absence of radiological findings already described; History of significant injury on collateral ligament, or anterior cruciate, or meniscus of the joint studied, with surgery, or immobilization for at least 3 weeks; Arthroscopy of the affected knee in last 6 months; Serum creatinine ≥ 1.8 mg/dL; Diagnosis of diabetes mellitus; Presence of any serious disease that could compromise the study, at the investigator discretion; History of adverse event or allergy to acetaminophen, glucosamine sulfate or chondroitin sulfate; Inability to understand and report the study questionnaire and the Visual Analogic Scale; Inability to understand and consent to participate in this clinical study, expressed by signing the Informed Consent (IC); Woman in pregnancy. If female of childbearing potential, has a negative urine pregnancy test at Visit 0 and do not use, or do not agree to use, for the duration of the study, a medically acceptable form of contraception as determined by the investigator; Alcohol intake ( &gt; 3 doses/day); Oral or intramuscular corticosteroids four weeks prior to study entry; Intraarticular injections with corticosteroids, into the studied knee, within the past three months; Intraarticular injections in any other joint within the past four weeks; NSAID users that don´t respect the washout period. Lowdose aspirin (325 mg or less, once daily) is allowed for cardioprotective benefit; Intraarticular injections of hyaluronic acid within the past 12 months; Use of topical analgesic in the joint studied or any other oral analgesic (with the exception of acetaminophen and other NSAID) two weeks prior to randomization; Implementation of any other medical treatment for osteoarthritis one month prior to study entry; Participation in last one year of clinical protocols, unless it can be direct benefit to patient; Use of glucosamine and/or chondroitin sulfate three and six months prior the study entry, respectively; Initiation of physical therapy two months prior to the study period; Use of tetracycline and oral anticoagulants; Use of vitamin D in doses in doses above the recommended; Patients in alternative therapies; Allergy to sulfonamides; Presence of psychiatric disorders that could compromise the study.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Knee Osteoarthritis;</keyword>
	<keyword>Glucosamine;</keyword>
	<keyword>Chondroitin.</keyword>
</DOC>